11. Acute exacerbations 143 Antje Prasse 12. Cancer 151 Carlo Vancheri 13. Pulmonary hypertension 160 Etienne-Marie Jutant, Laura Price, S. John Wort, Marc Humbert and David Montani 14. CPFE: distinctive and non-distinctive features 175 Athol U. Wells, George A. Margaritopoulos, Katerina M. Antoniou, Hilario Nunes and Ulrich Costabel 15. Other comorbidities 186 Michael Kreuter, Eva Brunnemer, Svenja Ehlers-Tenenbaum, Nicolas Kahn, Jacques Bruhwyler and Martin Kolb 16. Pharmacological management 196 Vincent Cottin and Claudia Valenzuela 17. Symptom management: dyspnoea and cough 218 Wim A. Wuyts 18. Nonpharmacological interventions: rehabilitation, palliative care and 230 transplantation Klaus Kenn, Rainer Gloeckl, Inga Heinzelmann and Nikolaus Kneidinger 19. Key patients’ needs: a patient’s perspective 243 Derek Ross 20. Key ongoing issues in trial design 253 Mark G. Jones and Luca Richeldi 21. Perspectives for the future 260 Toby M. Maher and Paolo Spagnolo
Previous Page Next Page